Dual-Targeted Therapy With Risankizumab and Upadacitinib Is Clinically and Biochemically Effective in Medically Complex CD.
| Publicado en: | Gastroenterology & Hepatology Vol. 21; pp. 15 - 17 |
|---|---|
| Formato: | tables/charts Journal Article |
| Publicado: |
Gastro-Hep Communications, Inc
2025 Supplement
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| Descripción no disponible. |